Undifferentiated Sarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-07-20
Clinical Trial Update: Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children [Phase 1]
A Phase 1 clinical trial of doxorubicin with hyperthermic intraperitoneal chemotherapy (HIPEC) and intraoperative brachytherapy for unresect…